Cargando…

Role of Impaired Oxalate Homeostasis in Cardiovascular Disease in Patients With End-Stage Renal Disease: An Opinion Article

Detalles Bibliográficos
Autor principal:	Stepanova, Natalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193726/ https://www.ncbi.nlm.nih.gov/pubmed/34122117 http://dx.doi.org/10.3389/fphar.2021.692429

Ejemplares similares

Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study
por: Stepanova, Natalia, et al.
Publicado: (2022)

Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease
por: Wang, Yinghui, et al.
Publicado: (2022)

Oxalate Homeostasis in Non-Stone-Forming Chronic Kidney Disease: A Review of Key Findings and Perspectives
por: Stepanova, Natalia
Publicado: (2023)

Editorial: Adipose Tissue in the Cardiovascular Homeostasis and Disease
por: Butcher, Joshua T., et al.
Publicado: (2021)

Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal Disease
por: Ermer, Theresa, et al.
Publicado: (2017)

Impact of Healthcare Associated Infections on Survival and Treatment Outcomes Among End Stage Renal Disease Patients on Renal Replacement Therapy
por: Abbasi, Saad Hanif, et al.
Publicado: (2021)

Diabetes and end-stage renal disease; a review article on new concepts
por: Ghaderian, Seyed Bahman, et al.
Publicado: (2015)

Cardiovascular Disease in Patients with End-Stage Renal Disease on Hemodialysis
por: Aoki, Jiro, et al.
Publicado: (2017)

The Role of Hydrogen Sulfide on Cardiovascular Homeostasis: An Overview with Update on Immunomodulation
por: Pan, Li-Long, et al.
Publicado: (2017)

Combined Cardiac Impairments in End-Stage Renal Disease
por: Sobieszczańska, Małgorzata, et al.
Publicado: (2012)

Metabolic and Network Pharmacological Analyses of the Therapeutic Effect of Grona styracifolia on Calcium Oxalate-Induced Renal Injury
por: Chen, Wei, et al.
Publicado: (2021)

Idiopathic Oxalate Nephropathy Leading to End-Stage Kidney Disease: A Case Report
por: Saleem, Maryam, et al.
Publicado: (2023)

Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal Dialysis
por: Bonomini, Mario, et al.
Publicado: (2019)

Diagnosis and Management of Cardiovascular Disease in Advanced and End‐Stage Renal Disease
por: Bhatti, Navdeep K., et al.
Publicado: (2016)

Statin Therapy for Hyperlipidemic Patients With Chronic Kidney Disease and End-Stage Renal Disease: A Retrospective Cohort Study Based on 925,418 Adults in Taiwan
por: Sung, Fung-Chang, et al.
Publicado: (2022)

The efficacy and safety of cuttlebone for lowering serum phosphate in patients with end-stage renal disease: a meta-analysis of randomized controlled trials
por: Chen, Hsiao-Tien, et al.
Publicado: (2023)

How Advanced Is Our Understanding of the Role of Intestinal Barrier Dysfunction in the Pathogenesis of Recurrent Urinary Tract Infections
por: Stepanova, Natalia
Publicado: (2022)

The Role of Necroptosis in Cardiovascular Disease
por: Zhe-Wei, Shi, et al.
Publicado: (2018)

Cognitive impairment and microvascular function in end‐stage renal disease
por: Angermann, Susanne, et al.
Publicado: (2022)

Cardiovascular risk in children and adolescents with end stage renal disease
por: do Val, Maria Luiza, et al.
Publicado: (2019)

Phyllanthus Niruri L. Exerts Protective Effects Against the Calcium Oxalate-Induced Renal Injury via Ellgic Acid
por: Li, Mao-Ting, et al.
Publicado: (2022)

Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study
por: Xiao, Xiang, et al.
Publicado: (2022)

Cpd-42 protects against calcium oxalate nephrocalcinosis-induced renal injury and inflammation by targeting RIPK3-mediated necroptosis
por: Hou, Bingbing, et al.
Publicado: (2022)

Corrigendum: Phyllanthus niruri L. exerts protective effects against the calcium oxalate-induced renal injury via ellgic acid
por: Li, Mao-Ting, et al.
Publicado: (2023)

The Emerging Role of Ferroptosis in Cardiovascular Diseases
por: Hong, Min, et al.
Publicado: (2022)

The Role of CXC Chemokines in Cardiovascular Diseases
por: Lu, Xiyi, et al.
Publicado: (2022)

The role of immune checkpoints in cardiovascular disease
por: Yousif, Laura I., et al.
Publicado: (2022)

Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease
por: Feldreich, Tobias, et al.
Publicado: (2018)

RNA Methylations in Cardiovascular Diseases, Molecular Structure, Biological Functions and Regulatory Roles in Cardiovascular Diseases
por: Zhou, Wanwan, et al.
Publicado: (2021)

Emodin in cardiovascular disease: The role and therapeutic potential
por: Guo, Yuanyuan, et al.
Publicado: (2022)

The Development of Practice Recommendations for Drug-Disease Interactions by Literature Review and Expert Opinion
por: van Tongeren, Justine M. Z., et al.
Publicado: (2020)

The Role of Bilirubin in Diabetes, Metabolic Syndrome, and Cardiovascular Diseases
por: Vítek, Libor
Publicado: (2012)

A Review Article: Access Recirculation Among End Stage Renal Disease Patients Undergoing Maintenance Hemodialysis
por: Zeraati, Abbasali, et al.
Publicado: (2013)

The Role of Plasma Neurofilament Light Protein for Assessing Cognitive Impairment in Patients With End-Stage Renal Disease
por: Hou, Yi-Chou, et al.
Publicado: (2021)

FUN14 Domain Containing 1 (FUNDC1): A Promising Mitophagy Receptor Regulating Mitochondrial Homeostasis in Cardiovascular Diseases
por: Mao, Yu, et al.
Publicado: (2022)

Reduced White Matter Integrity With Cognitive Impairments in End Stage Renal Disease
por: Yin, Yi, et al.
Publicado: (2018)

Mitochondrial homeostasis: a potential target for delaying renal aging
por: Yang, Ming, et al.
Publicado: (2023)

End Stage Renal Disease and Medicare
por: Greer, Joel W.
Publicado: (2003)

Cardiac STAT3 Deficiency Impairs Contractility and Metabolic Homeostasis in Hypertension
por: Altara, Raffaele, et al.
Publicado: (2016)

Editorial: Inflammation in Cardiovascular Diseases: Role of the Endothelium and Emerging Therapeutics
por: Qin, Cheng Xue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a764ujpelot6tato7s6g2d53dp